Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumors
- PMID: 22453573
- DOI: 10.1001/jama.2012.368
Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumors
Comment on
-
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.JAMA. 2012 Mar 28;307(12):1265-72. doi: 10.1001/jama.2012.347. JAMA. 2012. PMID: 22453568 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
